- Narducci DM
- Diamond AB
- Bernhardt DT
- Roberts WO
evidence of vaccine hesitancy in some groups has emerged.
- Ainslie D
- Ogwuru C
- Sinclair R
For athletic individuals, a key concern relates to the potential effect of vaccine-associated side-effects on sporting participation;
- Hull JH
- Schwellnus MP
- Pyne DB
- Shah A
even brief interruptions to training can affect athletic performance.
- Drew MK
- Raysmith BP
- Charlton PC
Complete data were available for 127 athletes (57 [45%] female, 70 [55%] male; mean age 27·5 years [SD 4·9]) who received two doses of the Pfizer-BioNTech vaccine tozinameran (BNT162b2), administered between May 12 and Sept 2, 2021, in line with licenced recommendations, from 435 athletes regularly using a COVID-19 monitoring application. Of these participants, 97 (76%) were Olympic sport athletes and 30 (24%) were Paralympic sport athletes, with 67 subsequently competing at the Tokyo Olympic Games and 22 competing at the Tokyo Paralympic Games.
- Menni C
- Klaser K
- May A
- et al.
Our findings indicate that continuation of sport after SARS CoV-2 vaccination is also appropriate. Indeed, exercising in the peri-vaccination period might enhance the immune response,
- Baker FL
- Smith KA
- Zúñiga TM
- et al.
although further studies in this area are required. Protecting elite athletes against SARS-CoV-2 infection is important, with a 2021 report indicating that around one in four have not returned fully to sport a month after the onset of infection.
- Hull JH
- Wootten M
- Moghal M
- et al.
Potential weaknesses of our study include the fact that the cohort was small and thus inadequately powered to detect infrequent adverse events. Our dataset also only provides insight regarding tozinameran; the UK vaccination strategy favoured use of this vaccine type in young individuals, and thus further work is needed to assess the impact of other SARS-CoV-2 vaccines in this population. Our methodological approach could also be used to evaluate tolerability and impact of non-SARS CoV-2 vaccines.
In conclusion, in elite athletes, vaccination against SARS-CoV-2 with the Pfizer-BioNTech vaccine tozinameran appears to be well tolerated and associated with few significant side-effects. When side-effects occurred, they were short-lived and did not affect sporting participation. This analysis should help to inform discussion regarding the risks and benefits of SARS-CoV-2 vaccination in the context of sport.
COVID vaccination in athletes and updated interim guidance on the preparticipation physical examination during the SARS-Cov-2 pandemic.
Clin J Sport Med. 2021; ()
Coronavirus and vaccine hesitancy, Great Britain: 9 August 2021.
- 3.Some GB Olympic athletes refusing COVID vaccine over side-effect fears.
COVID-19 vaccination in athletes: ready, set, go….
Lancet Respir Med. 2021; 9: 455-456
Injuries impair the chance of successful performance by sportspeople: a systematic review.
Br J Sports Med. 2017; 51: 1209-1214
Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study.
Lancet Infect Dis. 2021; 21: 939-949
- 7.Vaccination in elite athletes.
Sports Med. 2014; 44: 1361-1376
Acute exercise increases immune responses to SARS CoV-2 in a previously infected man.
Brain Behav Immun Health. 2021; 18100343
Clinical patterns, recovery time and prolonged impact of COVID-19 illness in international athletes: the UK experience.
Br J Sports Med. 2021; ()
Published: December 10, 2021
© 2021 Elsevier Ltd. All rights reserved.